Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering.

Reconstruction of highly efficient biosynthesis pathways is essential for the production of valuable plant secondary metabolites in recombinant microorganisms. In order to improve the titer of green tea catechins in Escherichia coli, combinatorial strategies were employed using the ePathBrick vectors to express the committed catechin pathway: flavanone 3β-hydroxylase (F3H), dihydroflavonol 4-reductase (DFR), and leucoanthocyanidin reductase (LAR). Three F3H, three DFR, and two LAR genes originating from different plant species were selected and synthesized, to create 18 pathway variants to be screened in E. coli. Constructs containing F3H(syn) originally from Camellia sinensis, DFR(syn) from Anthurium andraeanum, C. sinensis, or Fragaria ananass, and LAR(syn) from Desmodium uncinatum (p148, p158 and p168) demonstrated high conversion efficiency with either eriodictyol or naringenin as substrate. A highly efficient construct was created by assembling additional copies of DFR(syn) and LAR(syn) enabling a titer of 374.6 ± 43.6 mg/L of (+)-catechin. Improving the NADPH availability via the ΔpgiΔppc mutation, BLΔpgiΔppc-p148 produced the highest titer of catechin at 760.9 ± 84.3 mg/L. After utilizing a library of scaffolding proteins, the strain BLΔpgiΔppc-p168-759 reached the highest titer of (+)-catechin of 910.9 ± 61.3 mg/L from 1.0 g/L of eriodictyol in batch culture with M9 minimal media. The impact of oxygen availability on the biosynthesis of catechin was also investigated.

[1]  Tae Seok Moon,et al.  Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli. , 2010, Metabolic engineering.

[2]  Zachary L. Fowler,et al.  Improving NADPH availability for natural product biosynthesis in Escherichia coli by metabolic engineering. , 2010, Metabolic engineering.

[3]  M. Koffas,et al.  Characterization of dihydroflavonol 4-reductases for recombinant plant pigment biosynthesis applications , 2008 .

[4]  Jay D Keasling,et al.  BglBricks: A flexible standard for biological part assembly , 2010, Journal of biological engineering.

[5]  J. Keasling,et al.  High-level semi-synthetic production of the potent antimalarial artemisinin , 2013, Nature.

[6]  B. Gallois,et al.  Crystal structure of grape dihydroflavonol 4-reductase, a key enzyme in flavonoid biosynthesis. , 2007, Journal of molecular biology.

[7]  I. Abeysinghe,et al.  Flavonoid biosynthesis in the tea plant Camellia sinensis: properties of enzymes of the prominent epicatechin and catechin pathways. , 2004, Archives of biochemistry and biophysics.

[8]  Meghdad Hajimorad,et al.  BglBrick vectors and datasheets: A synthetic biology platform for gene expression , 2011, Journal of biological engineering.

[9]  M. Koffas,et al.  Standardized biosynthesis of flavan-3-ols with effects on pancreatic beta-cell insulin secretion , 2007, Applied Microbiology and Biotechnology.

[10]  Zachary L. Fowler,et al.  Genome-scale metabolic network modeling results in minimal interventions that cooperatively force carbon flux towards malonyl-CoA. , 2011, Metabolic engineering.

[11]  Jian Chen,et al.  Efficient Synthesis of Eriodictyol from l-Tyrosine in Escherichia coli , 2014, Applied and Environmental Microbiology.

[12]  Peng Xu,et al.  ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli. , 2012, ACS synthetic biology.

[13]  J. Keasling,et al.  Modular Engineering of l-Tyrosine Production in Escherichia coli , 2011, Applied and Environmental Microbiology.

[14]  J. Keasling,et al.  Integrating Biological Redesign: Where Synthetic Biology Came From and Where It Needs to Go , 2014, Cell.

[15]  C. Collins,et al.  Modular optimization of multi-gene pathways for fatty acids production in E. coli , 2013, Nature Communications.

[16]  N. Saari,et al.  Engineering the Production of Major Catechins by Escherichia coli Carrying Metabolite Genes of Camellia sinensis , 2012, TheScientificWorldJournal.

[17]  G. Stephanopoulos,et al.  Engineering E. coli for caffeic acid biosynthesis from renewable sugars , 2012, Applied Microbiology and Biotechnology.

[18]  Jay D Keasling,et al.  Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. , 2009, Metabolic engineering.

[19]  Blake A. Simmons,et al.  Synthesis of three advanced biofuels from ionic liquid-pretreated switchgrass using engineered Escherichia coli , 2011, Proceedings of the National Academy of Sciences.

[20]  Oliver Yu,et al.  Synthetic scaffolds increased resveratrol biosynthesis in engineered yeast cells. , 2012, Journal of biotechnology.

[21]  Mattheos A G Koffas,et al.  Metabolic pathway balancing and its role in the production of biofuels and chemicals. , 2015, Current opinion in biotechnology.

[22]  Gabriel C. Wu,et al.  Synthetic protein scaffolds provide modular control over metabolic flux , 2009, Nature Biotechnology.

[23]  H. Cheong,et al.  Alteration of a single amino acid changes the substrate specificity of dihydroflavonol 4-reductase. , 2001, The Plant journal : for cell and molecular biology.